Selexipag
CAS: 475086-01-2
Ref. TM-T3216
| 5mg | 49.00 € | ||
| 10mg | 63.00 € | ||
| 25mg | 90.00 € | ||
| 50mg | 94.00 € | ||
| 1ml*10 (DMSO) | 50.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
Product Information
Name:
Selexipag
Synonyms:
- NS-304, ACT-293987, Uptravi
- 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide
- 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide
- 2-[4-[(5,6-Diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
- Acetamide, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)-
- Acetamide, 2-[4-[(5,6-diphenylpyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)-
- Act 293987
- Ns 304
- Uptravi
CAS:
Description:
Selexipag (ACT-293987)(NS-304) is prostacyclin receptor agonist that causes vasodilation in pulmonary vasculature and is used in the therapy of pulmonary arterial hypertension (PAH).
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
496.62
Formula:
C26H32N4O4S
Purity:
99.92%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T3216 Selexipag
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
